TLR7 and HIV infectious disease: Studies have shown that the activation of TLR7/8-mediated signaling pathways upon treatment, with either ssRNA or the small molecule TLR7/8 agonist such as resiquimod (R-848), greatly reduced the ability of lymphoid tissue to support HIV infection [11,12,13].